Business Context and Reporting Period
This Form 8-K was filed by Sunshine Heart, Inc. on October 8, 2015. The filing reports upcoming events related to the company's C-Pulse device, specifically the presentation of hemodynamic data from pre-clinical studies and patient implants.
Key Events
- Analyst Breakfast: Scheduled for October 13, 2015, at 7:00 AM PST at the W Hotel San Francisco.
- TCT Symposium: Dr. Dimitrios Georgakopoulos (Chief Scientific Officer) will present data at the Transcatheter Cardiovascular Therapeutics conference on October 14, 2015.
- Presenters: Includes Dr. Leslie W. Miller (COUNTER-HF trial investigator) and Dr. William E. Cohn (Texas Heart Institute).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on upcoming scientific presentations and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document serves as a notification of future corporate events rather than a report on historical financial performance.
Outlook and Management Commentary
Management intends to demonstrate the mechanism of action of the C-Pulse system through hemodynamic data. The company anticipates that these presentations will provide insights into device optimization and sensor data. Recordings of the presentations will be made available on the company's investor relations website following the events.
Investor Verification Checklist
- Verify the date and location of the analyst breakfast (October 13, 2015, San Francisco).
- Confirm the specific hemodynamic data points to be presented at the TCT symposium.
- Review the attached press release (Exhibit 99.1) for detailed technical claims regarding the C-Pulse device.
- Check the investor relations website post-event for access to presentation recordings.